SOL SPA stock analysis
SOL SPA (0NJP) Share Price & Analysis
0NJP Stock Chart & Stats
- Day’s Range
- EUR 63.30 - EUR 63.70
- 52-Week Range
- EUR 45.15 - EUR 64.80
- Previous Close
- EUR 63.60
- Volume
- N/A
- Average Volume (3M)
- 2,077
- Market Cap
- EUR 5.77B
- Enterprise Value
- EUR 5.88B
- Total Cash (Recent Filing)
- EUR 312.81M
- Total Debt (Recent Filing)
- EUR 878.27M
- Price to Earnings (P/E)
- 33.3
- Beta
- 0.49
- Next Earnings
- Apr 01, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 0.70%
Bulls Say, Bears Say
Bulls Say
Consistent Revenue Growth
Consistent revenue expansion indicates sustained demand and broadening business activity over multiple years. The 2025 re-acceleration is encouraging because it suggests growth has not stalled, supporting continued investment, operating scale, and the potential for durable earnings progression.
Resilient Operating Margins
Stable mid-teens EBIT margins and strong EBITDA margins demonstrate meaningful operating profitability despite changing conditions. This profitability provides internal funding for growth and suggests the company has maintained pricing, mix, or cost discipline at the operating level.
Healthy Returns And Positive Cash Generation
Positive, fairly stable operating cash flow shows that the business converts its operations into cash, while historically healthy returns on equity indicate productive use of shareholder capital. Together, these support financial self-funding and demonstrate an established profitable operating model.
Bears Say
Declining Free Cash Flow
Declining free cash flow reduces the cash available for debt reduction, reinvestment, acquisitions, and shareholder returns. Because the 2025 amount was a small share of net income, reported profitability currently provides less financial flexibility than earnings alone would suggest.
Rising Leverage
The increase in debt and debt-to-equity weakens balance-sheet flexibility even though the overall leverage profile remains reasonable. Higher leverage can constrain future capital allocation and leave the company less resilient if interest rates remain elevated or earnings soften.
Gross Margin Volatility
Large swings in gross profitability introduce uncertainty into earnings quality and future margin durability. They may reflect variability in input costs, pricing, or product mix, meaning stable EBIT margins could require continued execution and may not fully protect results from underlying gross-margin pressure.
SOL SPA News
0NJP FAQ
What was SOL SPA’s price range in the past 12 months?
What is SOL SPA’s market cap?
When is SOL SPA’s upcoming earnings report date?
How were SOL SPA’s earnings last quarter?
Is SOL SPA overvalued?
Does SOL SPA pay dividends?
What is SOL SPA’s EPS estimate?
How many shares outstanding does SOL SPA have?
What happened to SOL SPA’s price movement after its last earnings report?
Which hedge fund is a major shareholder of SOL SPA?
What is the TipRanks Smart Score and how is it calculated?
Company Description
SOL SPA
SOL S.p.A., a global enterprise established in Monza, Italy, in 1927, operates as a subsidiary of Gas and Technologies World BV. The company primarily focuses on the research, manufacturing, and distribution of a diverse array of technical and medical gases, while simultaneously delivering comprehensive home healthcare solutions and associated medical equipment. Its extensive gas portfolio includes vital elements such as oxygen, nitrogen, and argon, alongside specialized gas mixtures, high-purity gases for the electronics industry, and food-grade gases. These products are supplied to various sectors including chemical, electronics, steel, metal, and food processing, as well as supporting environmental protection, scientific research, and healthcare. In the realm of home healthcare, SOL provides critical in-home therapies like oxygen, mechanical ventilation, and aerosol treatments. It also specializes in the diagnosis and management of respiratory sleep disorders, offers artificial nutrition programs, insulin pump therapy, immunotherapy, and dedicated support for pain and Parkinson's disease. Further extending its healthcare reach, the company delivers general home health and social care services, augmented by telemedicine platforms, digital health tools, and a range of healthcare aids. Beyond these core gas and home healthcare operations, SOL S.p.A. engages in a variety of complementary ventures. These encompass the design, construction, and management of biobanks; the generation and sale of hydroelectric power; and the provision of pre- and post-natal diagnostic screening. The company also develops and markets diagnostic systems and products for research and clinical applications across hospital, environmental, veterinary, and food sectors, alongside specialized bioshipping services for the secure transfer, storage, and handling of biological samples. Additional services include professional training, electromedical equipment support, hospital hygiene, environmental monitoring, and ambulance management, all facilitated by its proprietary InfoHealth SOLution web platform for operational oversight.
- Sector
- General
- Industry
- Chemicals - Specialty
- CEO
- Aldo Fumagalli Romario
- Employees
- 8,000
- Website
- www.solgroup.com
- Address
- Via Borgazzi, 27, Monza, MI, 20900, IT
SOL SPA (0NJP) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 14 | 5 | 3 |
| Technical Analysis | 2 | 5 | 3 |
| Moving Averages | 12 | 0 | 0 |



